HOME >> BIOLOGY >> NEWS
Hebrew University researcher wins prize for work leading to new anti-cancer drugs

A young Hebrew University of Jerusalem researcher has taken a significant step forward towards development of drugs that will be capable of repairing and "turning off" those elements that spur uncontrolled growth of cancerous tumors. This approach will eventually prove much less harmful and more effective than current chemotherapy treatment, which kills not only harmful but also healthy cells.

For his work, Mickey Kosloff -- who this year received his Ph.D. in biological chemistry at the university's Alexander Silberman Institute of Life Sciences -- is the recipient of one of this year's Kaye Innovation Awards, to be presented on May 27 at the university's 66th Board of Governors meeting. This is the tenth anniversary year for the awards.

Kosloff has analyzed the workings of the Ras protein that is found in all cells of the body. Mutant, defective Ras is involved in up to 30% of human cancers. In healthy tissue, Ras is a master switch controlling cell division and proliferation. It cycles between an "off" state that stops cell division, and an "on" state that drives cell division.

What occurs in the mutant Ras is that it loses its inherent enzymatic activity that enables it to be "turned off." The switch therefore remains stuck in the active ("on") state, thus driving the uncontrolled proliferation of "wild" cancer cells.

What Kosloff and other members of the research team headed by Kosloff's supervisor, Prof. Zvi Selinger, have done is to study G-proteins (and in particular the Ras protein within that group) to discover exactly what goes wrong with oncogenic, damaged Ras. Through combining intensive computational analysis of these proteins with an experimental methodology they called "substrate assisted catalysis," they were able to understand how the normal G-proteins turn themselves off and what goes wrong in the abnormal Ras. Importantly, they were also able to demonstrate that normal enzymatic activity can be restored t
'"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
The Hebrew University of Jerusalem
22-May-2003


Page: 1 2

Related biology news :

1. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
2. Defensive action by influenza viruses demonstrated by Hebrew university researcher
3. Earliest evidence of hereditary genetic disorder discovered by Hebrew University researchers
4. Scientists in Germany and Hebrew University illuminate process in control of flowering in plants
5. Hebrew University young researcher award goes to Dr. Nayef Jarrous
6. Hebrew University, German and British researchers develop means to help stress sufferers
7. Hebrew University Ph.D. graduate wins young scientist prize in US
8. Hebrew University researcher studies reorganization of brain in blind people
9. Hebrew University researchers develop method to improve neutraceutical absorption
10. Faster method for growing adult stem cells for bone regeneration developed at Hebrew University
11. Hebrew University excavations strengthen dating of archaeological findings to David, Solomon

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/7/2020)... ... August 06, 2020 , ... ... in the prestigious National STEM Scholar Program, a unique professional development program that ... project support for middle school science teachers nationwide. , Created in partnership between ...
(Date:7/31/2020)... ... 2020 , ... BioFactura, Inc. today announced a $1 million ... & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). ... efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has ... Invictus Medical Neoasis™ active noise control device to attenuate typical noises in a ... device attenuated the alarm sounds from patient monitors, ventilators and other bedside devices ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... SOUTH RIDING, Va. (PRWEB) , ... September 01, ... ... search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement ... Technologies . Averill will be responsible for leading all financial operations and implementing ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... chain validation engineering firm, is making available for free its new white ... incorporate concurrent transport simulation testing into today’s biologics licensing application (BLA). In ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering patients ... million stem cells total, patients may choose which extremities they would like treated. , ... (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a ...
(Date:7/31/2020)... ... July 29, 2020 , ... eSource has long been touted as the solution ... history of eSource, the reasons it did not take off as quickly as people ... the industry is moving towards capturing data electronically for clinical trials and then repurposing ...
Breaking Biology Technology:
Cached News: